Tech Company Financing Transactions

SpringWorks Therapeutics Funding Round

Bain Capital Double Impact, Bain Capital Life Sciences and LifeArc invested in a $103 million Series A funding round for SpringWorks Therapeutics. The financing was announced on 9/26/2017.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

100 Washington Blvd.
Stamford, CT 06902
USA

Phone

(203) 883-9490

Website

www.springworkstx.com

Email Address

[email protected]

Overview

SpringWorks Therapeutics (Nasdaq: SWTX) is a different type of therapeutic development company purpose-built for the 21st century. SpringWorks Therapeutics is on a mission to connect scientists, biopharmaceutical partners, patient groups, funders and philanthropists to deliver promising, transformative science to underserved patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Saqib Islam

        

Chief Medical Officer

Jens Renstrup

        

VP - Bus. Development

Badreddin Edris

        

VP - General Counsel

Michael Greco

        

VP - R & D

Mary Smith

        

VP - R & D

Stephen Squinto

        

Browse more venture capital transactions:

Prev: 9/26/2017: Deliveroo venture capital transaction
Next: 9/26/2017: PatientSafe Solutions venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary